Advertisement

  • Patient Advocates Tune in for Precision Medicine Primer

    Scientists and physicians discussed advances in targeted therapies and immunotherapies, as well as the lessons COVID-19 research has taught to cancer researchers.

    by Kevin McLaughlin

  • Immunotherapy Options for Breast Cancer

    Two immune checkpoint inhibitors are now approved for treatment of some people with advanced breast cancer, but trial results have raised some questions.

    by Anna Goshua

  • Are Liquid Biopsies Ready for the Clinic?

    Sophisticated blood tests offer a less invasive way to characterize cancers, guide treatment and catch recurrences sooner, but tissue biopsies remain the gold standard.

    by Kendall K. Morgan

  • Forward Look

    Scanning Disparities

    Whether lung cancer patients receive PET scans depends on race, according to a study.

    by Ashley P. Taylor

  • Forward Look

    Doing More With Less

    Hypofractionation may allow patients to finish radiation treatment sooner.

    by Stephen Ornes

  • Forward Look

    What’s Next?

    Using deep learning to detect tumor mutations.

    by Christina Bennett

  • Multiple Myeloma: Choosing Your Path

    New therapies provide hope and options for people as they monitor and manage this incurable blood cancer.

    by Tara Haelle

  • Physicians Underestimate Severity of Radiation Side Effects

    Breast cancer patients’ symptoms after radiation therapy may go underrecognized, especially if these patients are Black or younger in age.

    by Marci A. Landsmann

  • Drug Dependence After Breast Surgery

    A study indicates that some breast cancer patients who receive mastectomy and reconstruction may be at risk of persistent drug use following surgery.

    by Marcus A. Banks

  • Cancer Centers Cope With COVID-19 Surge

    Doctors at cancer centers in states with record COVID-19 hospitalization rates reflect on how lessons from early in the pandemic are helping them care for patients during the current surge.

    by Ashley P. Taylor

Advertisement
Advertisement

From the AACR

  • Prioritizing Vaccination

    The AACR led a contingent of 130 organizations in asking that cancer patients and survivors be granted high priority in receiving COVID-19 vaccinations.

  • Bolstering Diversity

    Eliminating disparities requires consistent effort on numerous fronts, including the development and sustenance of a diverse scientific workforce.

  • Screening During the Pandemic

    In March of last year, screenings for breast, colon and cervical cancer decreased by roughly 90% compared with historical rates.

Advertisement

Video

Learning Medicare’s ABCDs

Advertisement

social media

donate to the AACR